Sharps Technology Inc.

0.53
0.17 (47.76%)
At close: Feb 20, 2025, 3:59 PM
0.51
-3.59%
After-hours: Feb 20, 2025, 07:04 PM EST
undefined%
Bid 0.51
Market Cap 5.86M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -8.24
PE Ratio (ttm) -0.06
Forward PE n/a
Analyst Buy
Ask 0.52
Volume 74,263,595
Avg. Volume (20D) 1,700,467
Open 0.35
Previous Close 0.36
Day's Range 0.35 - 0.59
52-Week Range 0.30 - 18.15
Beta undefined

About STSS

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York....

Sector Healthcare
IPO Date Apr 14, 2022
Employees 57
Stock Exchange NASDAQ
Ticker Symbol STSS
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for STSS stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
3 weeks ago
-68.05%
Sharps Technology shares are trading lower after t... Unlock content with Pro Subscription
5 months ago
-26.78%
Sharps Technology shares are trading lower after the company announced that it has entered into definitive agreements with institutional investors for a secured bridge loan financing of approximately $3.5 million.